Well, that didn’t take long. On October 12, the Food and Drug Administration approved bivalent shots for some of the youngest among us, exactly six weeks after the federal agency authorized omicron-tailored boosters for those 12 and older. Final approval from the Centers for Disease Control also came on the same day.
Pfizer’s updated booster, which targets the OG strain as well as BA.4 and BA.5, is now approved for those as young as five; Moderna’s for children six and older. With this new authorization, kids in this age group are also eligible to get a second booster.
“Vaccination remains the most effective measure to prevent
→ Continue reading at SeattleMet